Follow
Hans Gelderblom
Hans Gelderblom
LUMC
Verified email at lumc.nl
Title
Cited by
Cited by
Year
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
A Grothey, E Van Cutsem, A Sobrero, S Siena, A Falcone, M Ychou, ...
The Lancet 381 (9863), 303-312, 2013
31052013
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
WTA Van Der Graaf, JY Blay, SP Chawla, DW Kim, B Bui-Nguyen, ...
The Lancet 379 (9829), 1879-1886, 2012
22442012
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom, J Verweij, K Nooter, A Sparreboom
European journal of cancer 37 (13), 1590-1598, 2001
21372001
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised …
GD Demetri, P Reichardt, YK Kang, JY Blay, P Rutkowski, H Gelderblom, ...
The Lancet 381 (9863), 295-302, 2013
14972013
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
I Judson, J Verweij, H Gelderblom, JT Hartmann, P Schöffski, JY Blay, ...
The lancet oncology 15 (4), 415-423, 2014
10232014
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ...
Annals of Oncology 29, iv51-iv67, 2018
9742018
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ...
Annals of Oncology 29, iv68-iv78, 2018
936*2018
Combination chemotherapy in advanced adrenocortical carcinoma
M Fassnacht, M Terzolo, B Allolio, E Baudin, H Haak, A Berruti, S Welin, ...
New England Journal of Medicine 366 (23), 2189-2197, 2012
9012012
The clinical approach towards chondrosarcoma
H Gelderblom, PCW Hogendoorn, SD Dijkstra, CS Van Rijswijk, AD Krol, ...
The oncologist 13 (3), 320-329, 2008
8402008
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
P Schöffski, S Chawla, RG Maki, A Italiano, H Gelderblom, E Choy, ...
The Lancet 387 (10028), 1629-1637, 2016
7942016
Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
ESMO/European Sarcoma Network Working Group
Annals of oncology: official journal of the European Society for Medical …, 2014
7122014
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, JY Blay, A Bertuzzi, S Bielack, B Bjerkehagen, S Bonvalot, ...
614*2014
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ...
Annals of Oncology 32 (11), 1348-1365, 2021
5462021
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, ...
Annals of Oncology 29, iv79-iv95, 2018
5402018
Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?
JK Anninga, H Gelderblom, M Fiocco, JR Kroep, AHM Taminiau, ...
European journal of cancer 47 (16), 2431-2445, 2011
5222011
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label …
NM Marina, S Smeland, SS Bielack, M Bernstein, G Jovic, MD Krailo, ...
The Lancet Oncology 17 (10), 1396-1408, 2016
5002016
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
S Smeland, SS Bielack, J Whelan, M Bernstein, P Hogendoorn, MD Krailo, ...
European journal of cancer 109, 36-50, 2019
4962019
Clinical pharmacokinetics of tyrosine kinase inhibitors
NP van Erp, H Gelderblom, HJ Guchelaar
Cancer treatment reviews 35 (8), 692-706, 2009
4712009
Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications
A Sparreboom, L Van Zuylen, E Brouwer, WJ Loos, P De Bruijn, ...
Cancer research 59 (7), 1454-1457, 1999
4381999
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Berruti, E Baudin, H Gelderblom, HR Haak, F Porpiglia, M Fassnacht, ...
Annals of oncology 23, vii131-vii138, 2012
4142012
The system can't perform the operation now. Try again later.
Articles 1–20